World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
46215
World Ranking
6983
National Ranking
3673

Overview

Vernon K. Sondak is affiliated with the University of South Florida in the United States. Their research primarily focuses on medicine, with a strong emphasis on oncology. Within oncology, their work further explores molecular biology, immunology, and epidemiology, with additional contributions related to electrical and electronic engineering.

The scientist's main research topics include:

  • Cutaneous Melanoma Detection and Management
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Melanoma and MAPK Pathways
  • Immunotherapy and Immune Responses
  • Polyomavirus and related diseases
  • Nonmelanoma Skin Cancer Studies

Vernon K. Sondak has contributed multiple papers in high-profile medical and oncology journals. Some of their recent papers are:

  • Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma, 2023, New England Journal of Medicine
  • Systemic Therapy for Melanoma: ASCO Guideline, 2020, Journal of Clinical Oncology
  • ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee, 2020, Annals of Oncology
  • Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma, 2021, Journal of Clinical Oncology
  • Systemic Therapy for Melanoma: ASCO Guideline Update, 2023, Journal of Clinical Oncology

Frequent coauthors who have collaborated extensively with Vernon K. Sondak include:

  • Ahmad A. Tarhini (41 joint publications)
  • Jonathan S. Zager (40 joint publications)
  • John M. Kirkwood (30 joint publications)
  • Nikhil I. Khushalani (30 joint publications)
  • Jane L. Messina (29 joint publications)

The scientist's work appears regularly in several publication venues, prominently:

  • Journal of Clinical Oncology (23 publications)
  • Annals of Surgical Oncology (17 publications)
  • Annals of Oncology (12 publications)
  • Journal for ImmunoTherapy of Cancer (9 publications)
  • Regular and Young Investigator Award Abstracts (9 publications)

Vernon K. Sondak's research career spans multiple domains within medicine and oncology, with a particular focus on melanoma and immunotherapy. Their interdisciplinary approach integrates molecular biology, immunology, and clinical oncology to advance understanding and management of skin cancers and associated immune responses.

Best Publications

  • Final Version of 2009 AJCC Melanoma Staging and Classification

    Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P.S.J. Meltzer;Y.D. Chen;Y. Jiang

  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

    Jeffrey E. Gershenwald;Richard A. Scolyer;Kenneth R. Hess;Vernon K. Sondak

  • High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

    John M. Kirkwood;Joseph G. Ibrahim;Jeffrey A. Sosman;Vernon K. Sondak

  • High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

    John M. Kirkwood;Joseph G. Ibrahim;Vernon K. Sondak;Jon Richards

  • Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

    Adil I. Daud;Ronald C. DeConti;Stephanie Andrews;Patricia Urbas

  • Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

    Edward L. Korn;Ping Yu Liu;Sandra J. Lee;Judith Anne W. Chapman

  • Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    Bianca D. Lemos;Barry E. Storer;Jayasri G. Iyer;Jerri Linn Phillips

  • A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for Melanoma

    John M. Kirkwood;Judith Manola;Joseph Ibrahim;Vernon Sondak

  • PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

    Kim H.T. Paraiso;Yun Xiang;Vito W. Rebecca;Ethan V. Abel

  • Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

    P Piedbois;M Buyse;N Kemeny

  • Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

    Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson

  • 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

    Jane L. Messina;David A. Fenstermacher;Steven Eschrich;Xiaotao Qu

  • Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database

    John F. Thompson;Seng Jaw Soong;Charles M. Balch;Jeffrey E. Gershenwald

  • Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study

    George J. Brewer;Robert D. Dick;Damanjit K. Grover;Virginia LeClaire

  • Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group

    Michael B. Atkins;Jessie Hsu;Sandra Lee;Gary I. Cohen

  • Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy

    K H T Paraiso;I V Fedorenko;L P Cantini;A C Munko

  • Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

    Vernon K. Sondak;Jeremy M. G. Taylor;Michael S. Sabel;Yue Wang

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P. Meltzer;Y. Chen;Y. Jiang

  • Abstract 5370: PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression

    Kim H. Paraiso;Vito Rebecca;Inna V. Fedorenko;Yun Xiang

Frequent Co-Authors

Jane L. Messina
Jane L. Messina University of South Florida
John M. Kirkwood
John M. Kirkwood University of Pittsburgh
Jeffrey A. Sosman
Jeffrey A. Sosman Northwestern University
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
John F. Thompson
John F. Thompson University of Sydney
Timothy M. Johnson
Timothy M. Johnson University of Michigan–Ann Arbor
Jeffrey S. Weber
Jeffrey S. Weber New York University
Adil Daud
Adil Daud University of California, San Francisco
Antoni Ribas
Antoni Ribas University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medical careers with flexible learning options? Online pathways now make it easier than ever to advance in healthcare without putting your life on hold. For current RNs, rn to bsn programs without clinicals provide a convenient route to a bachelor’s degree, often allowing students to bypass traditional on-site practicums.

Those seeking the highest level of clinical nursing practice can consider dnp programs online, which are available in accelerated and flexible formats for experienced nurses. Some online dnp programs without clinicals further lower barriers, accommodating professionals who want to advance without extensive in-person requirements.

If you’re starting your career, lpn online programs offer a fast-track entry into the workforce and can serve as stepping stones to higher qualifications. These innovative online options can help you tailor your educational journey, save time, and open doors to rewarding roles in the healthcare sector.

Best Scientists Citing Vernon K. Sondak

Trending Scientists